Key result
Head and neck chemoradiotherapy does not impair autonomic reflexes at 6 months despite higher resting HRV.
Why the study?
Radiotherapy for head and neck cancer irradiates the carotid sinus, yet early effects on cardiovascular autonomic function are poorly described.
Does definitive radical (chemo)radiotherapy impair cardiovascular autonomic function within six months in patients with head and neck cancer?
Observational (n=31)
No
Does definitive radical (chemo)radiotherapy impair cardiovascular autonomic function within six months in patients with head and neck cancer?
In patients with head and neck cancer undergoing radical (chemo)radiotherapy, conventional cardiovascular autonomic reflex tests show no significant deterioration within the first six months, and resting blood pressure variability changes are largely transient.
Supports continuing standard (chemo)radiotherapy without added autonomic monitoring in head and neck cancer; leaves open the clinical meaning of increased HF-HRV power.
Purpose Radiotherapy for head and neck cancer irradiates the carotid sinus, yet early effects on cardiovascular autonomic function are poorly described. We prospectively evaluated autonomic function before, at the end of, and six months after definitive radiotherapy with or without concurrent chemotherapy. Methods Thirty-one adults aged 18–74 years with squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx underwent autonomic function testing at baseline, at the end of treatment and at six months. Each session included a ten-minute supine recording for heart rate and blood pressure variability, followed by deep breathing, Valsalva manoeuvre, lying-to-standing, isometric handgrip and cold pressor tests. Repeated-measures analysis of variance and paired t-tests were used; analyses were exploratory and unadjusted for multiple comparisons. Results Twenty-nine patients completed the end-of-treatment assessment and seventeen the six-month assessment. High-frequency power of heart rate variability was higher than baseline at the end of treatment (P = 0.040) and at six months (P = 0.012). Systolic and diastolic blood pressure and their low-frequency variability increased at the end of treatment but not at six months. Deep breathing, Valsalva, lying-to-standing and handgrip responses did not change. The cold pressor diastolic response showed no overall change (P = 0.093); an isolated baseline-to-six-month difference (P = 0.049) indicated a smaller pressor rise. Conclusion Within six months, conventional autonomic reflex tests showed no significant deterioration, and changes in resting variability were mostly transient. These exploratory findings do not establish baroreflex dysfunction; longer follow-up with direct measurement of baroreflex sensitivity is needed.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) conducted an observational in Head and neck squamous cell carcinoma (n=31). Definitive radical radiotherapy with or without concurrent chemotherapy (cisplatin or carboplatin) vs. Pre-treatment baseline was evaluated on High-frequency (HF) power of resting heart rate variability (baseline vs 6 months) (p=0.012). Definitive (chemo)radiotherapy for head and neck cancer did not impair conventional autonomic reflexes over 6 months, though resting high-frequency HRV power increased from 28.50 to 40.91 (P=0.012).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: